Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia

Therapeutic Plasma Exchange in Refractory VITT Three patients with severe manifestations of VITT after Covid-19 vaccination had a poor response to initial therapy with anticoagulants and intravenous immune globulin. Their conditions improved after therapeutic plasma exchange was initiated, and they were able to leave the hospital.

Automated summary

Therapeutic plasma exchange was effective in treating refractory VITT in three patients, who showed poor response to initial therapy with anticoagulants and intravenous immune globulin. Their conditions improved and they were discharged from the hospital after the treatment.